title: [Prostate cancer, the urologist, the patient, and treatment].
abstract: Prostate cancer, particularly advanced prostate cancer, should be considered as a chronic disease that requires multidisciplinary management. Each health professional involved the urologist of course, but also the other therapists, especially the general practitioner and nurse, should place their activities within a therapeutic synergy. The onco-psychological dimension should not be underestimated. In particular, information about the disease, its course and the therapeutic solutions proposed should be given gradually and, above all, should be regularly recapitulated. Patients are more accepting of treatments when they know about them. The point of view of the patient with prostate cancer is approached here in two ways; firstly through the comments of a psychologist on the history of a patient with prostate cancer and the dialogue with an experienced urologist. The treatment should not only be understood, but also accepted and requested by the patient. In this chronic disease, the patient often feels the treatment to be a bond between the therapist and himself. A survey based on an auto-questionnaire was also conducted among 275 patients and 50 urologists in order to investigate these relationships. From the results of this survey, in the case of hormone treatment, a quarterly rhythm for LHRH agonist injections appears to be perfectly matched to patient requirements. Monthly injections involve too great an intrusion by the treatment into the life of a cancer patient, in contrast injections which are spaced at greater than quarterly intervals could be seen to much as desertion and also lead to forgetfulness and neglect.
authors.affiliation: Psychologue conseil à la ligue nationale contre le cancer où il intervient dans des groupes de parole de patients ayant un cancer de la prostate. alainbouregba@club-internet.fr
authors.forename: A
authors.initials: A
authors.lastname: Bouregba
authors.forename: T
authors.initials: T
authors.lastname: Lebret
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives; D006801:Humans; D007267:Injections; D008297:Male; D010819:Physician's Role; D010817:Physician-Patient Relations; D010821:Physicians, Family; D011471:Prostatic Neoplasms / Q000628:therapy*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D007987:Gonadotropin-Releasing Hormone